Zscaler Is Down 23% in a Year. That Makes It PANW’s Most Compelling Problem.
With CyberArk closed and SASE heading toward $39B by 2031, PANW has a gap only one company can fill.
Your book is inside
A note from our friends at Tradewins(ad) Blane Markham here, with an alert! If you still haven’t saved your copy…
Carvana Reports Tonight Into a Credit Storm
October 28, 2026 With subprime auto delinquencies near multi-decade highs and the 10-year near 5%, defined-risk options beat carrying CVNA…
Alphabet Has Fallen 22% From Its High. Tonight’s Cloud Numbers Could End That.
Google Cloud surged 82% in Q2. A $514B backlog hints Q3 could, too.
SK Hynix Is Earning 78% Margins. The Stock Says Nobody Believes It.
Tonight’s fight is not one quarter, it’s whether memory’s best days are over.
Big Gains on Tap as Sub-US$1 Silver-Gold Discovery Takes Shape
A note from our friends at Resource Stock Digest(ad) Silver and gold are obliterating all previous profit records with next-level…
Korea’s GDP Beat Tripled Forecasts. The KOSPI Proved It.
A semiconductor-led Q3 beat and Anthropic’s IPO filing triggered Seoul’s second buy-side circuit halt in six days, here is how to trade it.
Honeywell Spun Off Its Armor Business. The Market Hasn’t Priced It Yet.
Honeywell no longer owns its armor business. That sentence matters more than most people realize when talking about graphene-infused smart…
Merck’s Biggest Week: Cancer Data and Earnings
Q3 results Oct. 29 and an Oct. 26 oncology event sharpen focus on Merck’s post-2028 plan.
Free today, $29.97 tomorrow
A note from our friends at Profits Run(ad) Quick note. My new report, The 0DTE Game Plan, normally sells for…